Skip to content
Health X Platform logo

Health X Platform

HEALTHX NSE
₹278.80 3.40 (1.23%)
Market Cap
₹887 Cr
P/E
34.04

Health X Platform (HEALTHX) share price was ₹278.80 at the 28 Oct 2026 close; market capitalisation ₹887 Cr; P/E (TTM) 34.04; sector Healthcare Services. The share price fell 7.0% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Dec 2025 quarter, revenue rose 22.9% year on year to ₹345.74 Cr and net profit was ₹0.37 Cr, against −₹37.80 Cr a year earlier (compared with Dec 2024). Promoters held 74.07% of Health X Platform in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 36/100 (Poor) as of 28 Oct 2026.

Close 28 Oct 2026 ₹278.80 −21.10 −7.04% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹887 Cr
P/E (TTM)
34.04
EBITDA
₹6.20 Cr
Return on Equity
-0.19%
Debt to Equity
0
Book Value
₹201.47
EPS (TTM)
₹8.19
52W High
₹363.00
52W Low
₹252.50

Price-based figures as of 28 Oct 2026, 15:31 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Dr Lal Pathlabs
₹1,922.3059.4432,266 Cr12.860.26%20.06%25.67%2,996 Cr545 Cr
Vijaya Diagnostic Centre
₹1,442.8079.1414,861 Cr15.530.14%18.07%19.22%879 Cr187 Cr
Metropolis Healthcare
₹551.2056.6511,431 Cr7.610.91%12.54%15.73%1,733 Cr203 Cr
Thyrocare Technologies
₹494.5044.637,871 Cr15.352.84%27.79%33.84%894 Cr176 Cr
Nephrocare Health Services
₹628.40149.986,319 Cr5.660.00%6.88%13.46%1,079 Cr85 Cr
Suraksha Diagnostic
₹311.7045.311,623 Cr6.630.16%12.90%14.70%329 Cr35 Cr
Krsnaa Diagnostics
₹496.4516.281,610 Cr1.640.40%10.35%10.64%862 Cr98 Cr
Health X Platform (this company)
₹278.8034.04887 Cr1.380.00%-0.19%-0.20%1,513 Cr29 Cr
Median 8 companies₹523.8350.987,095 Cr7.120.21%12.72%15.22%987 Cr137 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
36 Poor
Overall score
Data confidence 98/100

Category scores

Quality Poor 16
Returns, margins, earnings quality 22%
Valuation Average 47
Cheap vs sector & own history 24%
Growth Poor 33
Sales & profit trajectory 9%
Financial Health Poor 35
Solvency, leverage, coverage 9%
Momentum Poor 31
Trend strength, vol-adjusted 12%
Ownership Average 51
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

4
  • Company is almost debt free.
  • Company has delivered good profit growth of 23.3% CAGR over last 5 years
  • Company's median sales growth is 39.5% of last 10 years
  • Company's working capital requirements have reduced from 66.1 days to 47.0 days

Weaknesses

2
  • Company has a low return on equity of -1.12% over last 3 years.
  • Earnings include an other income of Rs.66.2 Cr.

Technical Indicators

Oscillators

BearishNeutralBullish

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

BearishNeutralBullish

Bearish

Bearish
10
Neutral
7
Bullish
2

Moving Averages

BearishNeutralBullish

Bearish

Bearish
8
Neutral
0
Bullish
2

Growth Rate

Revenue Growth
17.65% higher than 3Y

change over 1 year

Net Income Growth
-98.95% lower than 3Y

change over 1 year

Cash Flow Change
-327%

change over 1 year

EBITDA Margin Change
36.36%

change over 1 year Operating margin -3% · Dec 2025

Analyst Forecasts

Forecast For
FY27 consensus · ROE
-13.0% −6742.1% vs FY26
Reported High Mean Low

Quarterly Results

Particulars Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales
281
313
336
358
375
307
270
274
281
286
298
301
346
Expenses
291
324
327
355
371
317
273
278
305
311
292
324
356
Operating Profit
-10.08
-11.17
9.26
3.37
3.43
-10.65
-2.4
-4.72
-23.7
-25.2
6.06
-22.61
-10.36
OPM %
-3.59%
-3.57%
2.76%
0.94%
0.92%
-3.47%
-0.89%
-1.73%
-8.43%
-8.82%
2.03%
-7.5%
-3%
Other Income
4.01
8.63
12.11
9.71
20.13
18.46
28.75
-167
-14.06
21.91
25.38
5.34
13.62
Interest
0.27
0.26
0.25
0.24
0.24
0.27
0.1
0.06
0.05
0.01
0.09
0.04
0.17
Depreciation
2.4
2.8
2.09
2.2
2.31
2.53
1.61
1.45
1.43
1.34
1.17
1.33
2.17
PBT
-8.74
-5.6
19.03
10.64
21.01
5.01
24.64
-174
-39.24
-4.64
30.18
-18.64
0.92
Tax %
-70.48%
287.5%
-28.85%
-23.03%
3.86%
-583.03%
-102.8%
-13.17%
1.99%
-478.45%
11.9%
-17.17%
59.78%
Net Profit
-26.37
-48
-0.28
-12.2
-3.23
21.58
40.96
-155
-37.8
17.57
26.59
-15.44
0.37
EPS (₹)
-6
-10.75
0.41
-2.55
-0.24
5.17
9.79
-34.39
-8.47
4.3
7.52
-3.99
0.36
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
30
52
89
135
162
222
388
551
1,798
1,060
1,432
1,159
1,231
Expenses
35
62
116
155
175
255
440
561
684
1,168
1,456
1,177
1,283
Operating Profit
-4
-10
-28
-20
-13
-33
-52
-10
1,114
-107
-24
-19
-52
OPM %
-15%
-19%
-31%
-15%
-8%
-15%
-13%
-2%
62%
-10%
-2%
-2%
-4%
Other Income
0
2
0
2
7
0
1
1
3
-5
4
-179
66
Interest
1
1
2
3
1
3
1
3
3
2
1
0
0
Depreciation
2
6
7
7
6
6
5
4
4
8
9
6
6
PBT
-7
-15
-37
-28
-12
-42
-58
-16
1,109
-122
-30
-204
8
Tax %
-5%
0%
-1%
2%
19%
3%
-9%
4%
22%
-19%
-119%
-34%
—
Net Profit
-6
-15
-37
-29
-15
-43
-52
-17
865
-99
6
-134
29
EPS (₹)
-2.03
-4.68
-11.51
-9
-3.73
-11.81
-12.19
-3.27
197
-22.7
2.79
-28.66
8.19
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
32
32
32
32
32
32
32
32
32
32
32
32
32
Reserves
238
223
186
163
144
111
178
168
795
722
731
638
650
Borrowings
0
5
19
21
12
2
8
12
2
9
4
1
5
Other Liabilities
39
22
20
35
48
86
98
80
449
441
383
300
321
Total Liabilities
309
281
256
251
235
230
316
293
1,278
1,204
1,149
970
1,008
Fixed Assets
117
137
126
125
117
116
114
110
93
107
110
102
117
CWIP
0
3
0
0
1
1
0
0
0
1
0
10
1
Investments
41
22
10
17
46
36
56
43
666
513
676
575
633
Other Assets
151
119
120
110
71
77
146
139
518
583
363
283
257
Total Assets
309
281
256
251
235
230
316
293
1,278
1,204
1,149
970
1,008
Figures in ₹ Crores

Cash Flow

Particulars Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating
36
-12
-12
-2
-49
-30
-69
-31
-207
-112
36
-17
Investing
-42
7
-1
4
15
-2
-22
21
220
133
-34
-1
Financing
-3
4
13
5
33
26
103
4
-11
-2
-2
0
Net Cash Flow
-10
-1
0
7
-2
-6
11
-5
1
19
0
-19
Free Cash Flow
15
-28
-18
0
-55
-33
-71
-31
-212
-128
22
-27
CFO/OP
-845
106
43
17
377
89
133
288
-8
104
-172
68
Figures in ₹ Crores

Ratios

Particulars Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
169
87
34
52
9
13
14
9
4
12
9
3
Inventory Days
—
337
91
80
73
59
77
57
71
69
34
40
Days Payable
—
165
38
69
24
26
50
29
21
22
13
21
Cash Conversion Cycle
169
259
87
62
58
46
41
38
55
59
31
22
Working Capital Days
441
344
182
49
61
61
54
44
46
93
58
47
ROCE %
-2%
-6%
-14%
-12%
-8%
-19%
-25%
-6%
-7%
-11%
-3%
-1%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Health X Platform insights

64 extracted metrics + investor summaries across FY11–FY27.

Shareholding Pattern

FIIs2.32%Promot.74.07%DIIs2.61%Others9.04%Public11.95%As ofSep 2026

Documents

Frequently Asked Questions about Health X Platform

What does Sastasundar Ventures Ltd do?
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services[1]
Where is Sastasundar Ventures Ltd (HEALTHX) listed?
Sastasundar Ventures Ltd trades as HEALTHX on the NSE and under code 533259 on the BSE.
Which sector does Sastasundar Ventures Ltd belong to?
Sastasundar Ventures Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd has a market capitalisation of ₹886.88 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd trades at a PE ratio of 34.04 as of 28 Oct 2026, on earnings per share of ₹8.19, against a book value of ₹201.47 per share.
What is the 52-week high and low of Sastasundar Ventures Ltd?
Over the last 52 weeks Sastasundar Ventures Ltd has traded between ₹252.5 and ₹363 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd reported a return on equity of -0.19%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services[1]

Website sastasundarventures.com
CEO Mr. Banwari Lal Mittal
Employees 1,657
Listed 2010-10-05
Face Value ₹ 10
Shares Outstanding 3,18,10,500

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SASTASUNDR.md for Sastasundar Ventures Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month